CYRX
Cryoport Inc
17.40$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.3% | -1.6% | -9.6% | -17.7% | +0.2% | -0.5% | +0.0% | +10.6% | -1.2% | -0.2% | -1.0% | |
| – | -2.6% | -1.8% | -4.5% | -30.2% | -2.5% | +20.4% | +0.0% | +17.9% | -1.8% | -1.2% | -2.2% | |
| – | -22.1% | +7.2% | -6.5% | -3.9% | +1.4% | -20.3% | +0.0% | +608.6% | -2.1% | +8.9% | -1.3% | |
| – | -2.0% | -1.8% | -4.8% | -36.2% | -4.0% | -6.8% | +0.0% | +72.6% | -2.4% | -1.8% | -1.7% | |
| – | -1.3% | -2.0% | -2.6% | +8.2% | +5.3% | -38.0% | +0.0% | +23.1% | -4.5% | +16.9% | -6.5% | |
| – | -10.0% | -4.5% | -5.6% | -0.2% | -4.6% | +3.9% | +0.0% | -0.1% | -0.6% | -6.2% | -1.1% | |
| – | -27.2% | -0.8% | -51.3% | +3.2% | -4.4% | -59.4% | +0.0% | +6.9% | 0.0% | -1.2% | -0.3% | |
| – | +0.7% | -2.2% | -6.2% | -1.4% | -3.0% | -14.7% | +0.0% | -2.9% | -2.2% | +0.5% | -2.0% | |
| – | +1.2% | +0.4% | -3.9% | -37.4% | +6.5% | -0.2% | +0.0% | -13.3% | +0.5% | +2.4% | -1.2% | |
| – | +1.6% | +7.4% | +22.3% | +2.6% | +5.1% | +14.7% | +0.0% | -58.5% | +612.3% | +2.7% | -1.7% | |
| – | +15.6% | -0.7% | +247.1% | +3.5% | -1.8% | -9.2% | +0.0% | -75.4% | +4,068.0% | -0.1% | +0.3% | |
| – | -6.5% | +5.1% | -9.4% | +1.6% | +3.9% | -48.6% | +0.0% | +3.3% | +10.1% | +4.3% | +1.9% | |
| – | +0.4% | +0.2% | -6.2% | -48.2% | +0.1% | +0.2% | +0.3% | +0.1% | -99.4% | -5.5% | -4.1% | |
| – | -9.0% | -3.4% | -15.3% | +4.6% | -4.0% | -0.8% | +0.0% | +28.7% | -2.1% | -1.5% | -0.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.1% | +0.7% | +0.1% | +0.4% | +0.7% | +0.6% | -0.3% | -0.7% | +0.3% | +1.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.